Alcon 3Q profit down 18 percent without tax gain
Seattle Times (Free subscription) | 28/10/2009
Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit.
Your search relates to more than one category
Seattle Times (Free subscription) | 28/10/2009
Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit.
Seattle Post-Intelligencer (Free subscription) | 28/10/2009
NEW YORK -- Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit.
Business Wire (Free subscription) | 27/10/2009
HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE:ACL) reported global sales rose 5.9 percent to $1,614 million for the third quarter of 2009, or a 9.0 percent increase excluding the impact of foreign exchange fluctuations. Net earnings for the third quarter of 2009 were $515 million, or $1.71 per diluted share. Excluding the impact of a $240 million tax benefit related to the...
Click here to see all comments
MAXIDEX DEXAMETHAONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
San Fransisco Chronicle (Free subscription) | 28/10/2009
Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit. Alcon's profit slipped to $515 million, or $1.71 per share, from $627 million, or $2.07 per share, in the... Sponsored Topics: Tax - Taxation - United States - Accounting - Society and Culture
Seattle Post-Intelligencer (Free subscription) | 28/10/2009
Last updated October 28, 2009 3:30 p.m. PTEarnings roundup: CommVault, AlconTHE ASSOCIATED PRESSAmong the earnings stories for Wednesday, Oct. 28, from AP Financial News:OCEANPORT, N.J. -- CommVault Systems Inc. reported a flat fiscal second-quarter profit as rising operating expenses and revenue costs overshadowed an increase in sales.NEW YORK -- Eye drug maker Alcon Inc....
Click here to see all comments
MAXIDEX DEXAMETHASONE WRNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
PR News Wire (Free subscription) | 23/10/2009
LOUISVILLE, Ky., Oct. 23 /PRNewswire/ -- Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements with Alcon Research, Ltd., a wholly-owned subsidiary of Alcon, Inc. (NYSE: ACL). The agreements provide Alcon...
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Red Orbit (Free subscription) | 23/10/2009
Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with AlconPosted on: Friday, 23 October 2009, 07:00 CDT LOUISVILLE, Ky., Oct. 23 /PRNewswire/ -- Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements...
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX (dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Business Wire (Free subscription) | 06/10/2009
HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE: ACL) will report on its third quarter financial results for the period ended September 30, 2009 after the market close on Tuesday, October 27, 2009. Management of the company will host a conference call to discuss these results on Wednesday, October 28, 2009, at 8:30 a.m. Eastern Time. Presenting from Alcon will be Kevin...
Market Wire (Free subscription) | 01/10/2009
NEW YORK, NY (MARKET WIRE) Did you know that India accounts for nearly 20 percent of all blind children worldwide? ORBIS International's flagship Flying Eye Hospital arrived in Jaipur, India with its international team of volunteer eye care specialists and global sponsor Alcon, Inc. (NYSE: ACL), the world's leading eye care company. Invited by the Ministry of Health Services, hosted by...
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX (dexamethasone) drops by ALCON LABS. Two says later I was BLIND Use Google and enter EPOCRATES...
Market Wire (Free subscription) | 30/09/2009
NEW YORK, NY (MARKET WIRE) ORBIS International's flagship Flying Eye Hospital arrived in Jaipur, India with its international team of volunteer eye care specialists and global sponsor Alcon, Inc. (NYSE: ACL), the world's leading eye care company. Invited by the Ministry of Health Services, hosted by the Sahai Eye Hospital and Research Centre, S.M.S Medical College and generously sponsored...
iStockAnalyst.com (Free subscription) | 30/10/2009
Today's tickers: ACL, VIX, FEED, ODP, NRG, NVTL, LVS & MSTR [More...]
The Earth Times Online Newspaper (Free subscription) | 28/10/2009
EMERYVILLE, Calif., Oct. 28 -- NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY) will hold a webcast conference call on October 30, 2009 to review preclinical data from a study of Aganocide® product candidates NVC-422 and NVC-612 in a model of onychomycosis, com...
Law Blog - WSJ.com (Free subscription) | 22/10/2009
Novartis raised its full-year sales outlook, although it reported flat third-quarter net profit as higher revenue was offset by charges related to its holdings in Alcon and Roche and as growth slowed in its profitable best-sellers.
Click here to see all comments
MAXIDEX DEXAMETHASONE wArnINg
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
SeekingAlpha.com (Free subscription) | 18/10/2009
... almost certainly wind down, perhaps there are some good short opportunities. Name Ticker 1 EBAY INC EBAY 2 GOOGLE INC GOOG 3 APPLE INC AAPL 4 OSI PHARMACEUTICALS... OSIP 5 BANK OF AMERICA COR... BAC 6 JP MORGAN CHASE & CO JPM 7 CISCO SYS INC CSCO 8 SPDR S&P 500 SPY 9 DELL INC DELL 10 NVIDIA CORP NVDA 11 E M C CORP MASS EMC 12 WYETH WYE 13 PEPSI BOTTLING GROU... PBG 14 MEMC ELECTR MATLS...
Research Recap (Free subscription) | 19/10/2009
... billion) share repurchase program. Erskine also expects Nestle will probably sell its stake in Alcon Inc. (ACL) “sooner rather than later,” potentially generating net cash of 8 billion Swiss francs by early 2010. Nestle has a put option to sell its 52 percent Alcon stake to Novartis AG (NOVN) between January 2010 and July 2011. For previous ResearchRecap posts on Cadbury ahead...